Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.79 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.65 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 5/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.55 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.55 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.55 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | GGT1 | P19440 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8926671 | 0.94 | ALDH1A1 (0.76) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL29400029 | 0.94 | ALDH1A1 (0.76) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL571511 | 0.94 | ALDH1A1 (0.76) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL2049483 | 0.94 | ALDH1A1 (0.89) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL30211332 | 0.94 | ALDH1A1 (0.89) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL2451111 | 0.93 | ALDH1A1 (0.90) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL3383338 | 0.91 | ALDH1A1 (0.67) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL14399041 | 0.90 | ALDH1A1 (0.71) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL122684 | 0.90 | ALDH1A1 (0.71) | ALDH1A1KMT2APTK2BKDM4EHTT | |
| SCHEMBL8731293 | 0.90 | ALDH1A1 (0.71) | ALDH1A1KMT2APTK2BKDM4EHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161539-A1 | INJECTION OF COLLAGEN ELASTIN HYDROGEL MICROPARTICLES INTO TORN TENDONS AND LIGAMENTS | PETVIVO HOLDINGS INC (US) | 2025-05-22 | — | — | US | claimed |
| US-20240285517-A1 | Biocompatible Protein-Based Particles and Methods Thereof | PETVIVO HOLDINGS, INC. (US) | 2024-08-29 | — | — | US | claimed |
| US-11890371-B2 | Biocompatible protein-based particles and methods thereof | PETVIVO HOLDINGS, INC. (US) | 2024-02-06 | — | — | US | claimed |
| US-11571389-B2 | Delivery devices and methods for making the same | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-02-07 | — | — | US | claimed |
| US-20210052507-A1 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | UNIV JOHNS HOPKINS (US) | 2021-02-25 | — | — | US | claimed |
| US-20190117855-A1 | PROTEIN BIOMATERIAL AND BIOCOACERVATE VESSEL GRAFT SYSTEMS AND METHODS OF MAKING AND USING THEREOF | GEL-DEL TECHNOLOGIES, INC | 2019-04-25 | — | — | US | claimed |
| US-20180344656-A1 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE | 2018-12-06 | — | — | US | claimed |
| US-10016534-B2 | Protein biomaterial and biocoacervate vessel graft systems and methods of making and using thereof | GEL-DEL TECHNOLOGIES, INC. (US) | 2018-07-10 | — | — | US | claimed |
| US-20160256404-A1 | Drugs and Gene Carrier Particles That Rapidly Move Through Mucous Barriers | JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE | 2016-09-08 | — | — | US | claimed |
| US-9107937-B2 | Wound treatments with crosslinked protein amorphous biomaterials | GEL-DEL TECHNOLOGIES, INC. (US) | 2015-08-18 | — | — | US | claimed |
| EP-1528894-A2 | BIOMATRIX STRUCTURAL CONTAINMENT AND FIXATION SYSTEMS AND METHODS OF USE THEREOF | Gel-Del Technologies, Inc. (US) | 2005-05-11 | — | — | EP | claimed |
| WO-2005034852-A2 | PROTEIN BIOMATERIALS AND BIOCOACERVATES AND METHODS OF MAKING AND USING THEREOF | GEL-DEL TECHNOLOGIES, INC. (US) | 2005-04-21 | — | — | WO | claimed |
| US-20050058688-A1 | Device for the treatment and prevention of disease, and methods related thereto | BOERGER LARS (DE) | 2005-03-17 | — | — | US | claimed |
| EP-1435911-A1 | DEVICES INCLUDING PROTEIN MATRIX MATERIALS AND METHODS OF MAKING AND USING SAME | Gel-Del Technologies, Inc. (US) | 2004-07-14 | — | — | EP | claimed |
| WO-2003092468-A2 | BIOMATRIX STRUCTURAL CONTAINMENT AND FIXATION SYSTEMS AND METHODS OF USE THEREOF | GEL-DEL TECHNOLOGIES, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| WO-2003015754-A1 | DEVICES INCLUDING PROTEIN MATRIX MATERIALS AND METHODS OF MAKING AND USING SAME | GEL-DEL TECHNOLOGIES, INC. (US) | 2003-02-27 | — | — | WO | claimed |
| US-20030007991-A1 | Devices including protein matrix materials and methods of making and using thereof | GEL-DEL TECHNOLOGIES, INC. | 2003-01-09 | — | — | US | claimed |
| EP-1259223-A1 | PROTEIN MATRIX MATERIALS, DEVICES AND METHODS OF MAKING AND USING THEREOF | Gel-Del Technologies, Inc. (US) | 2002-11-27 | — | — | EP | claimed |
| US-20020028243-A1 | Biocompatible protein materials compressed with one or more biocompatible solvents to remove bulk solvent and form an interacting protein matrix material. | PETVIVO HOLDINGS, INC. | 2002-03-07 | — | — | US | claimed |
| WO-2001087267-A1 | PROTEIN MATRIX MATERIALS, DEVICES AND METHODS OF MAKING AND USING THEREOF | GEL-DEL TECHNOLOGIES, INC. (US) | 2001-11-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210052507-A1 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | ABCB11, ABCB1, SLC47A2 | ALDH1A1 891/4885KMT2A 4727/4885PTK2B 3528/4885 |
| US-20160256404-A1 | Drugs and Gene Carrier Particles That Rapidly Move Through Mucous Barriers | ABCB11, ABCB1, SLC47A2 | ALDH1A1 891/4885KMT2A 4727/4885PTK2B 3528/4885 |
| US-20180344656-A1 | DRUGS AND GENE CARRIER PARTICLES THAT RAPIDLY MOVE THROUGH MUCOUS BARRIERS | ABCB11, ABCB1, SLC47A2 | ALDH1A1 891/4885KMT2A 4727/4885PTK2B 3528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.